Delivery Order SPE2DR25D3303-SPE2DR26F62D5
Award Date 11/25/25
Potential Completion Date 12/17/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 8, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Envarsus XR 1 mg tablets (30-count) at a ceiling value of $1,553.40. The contract is a firm fixed-price delivery order with an ultimate completion date of May 30, 2025, and was competitively awarded without set-aside designation. This award represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, valued at $1,288.86 for the supply of Envarsus XR 1 mg tablets (100-count units) to the Department of Defense Medical Supply Chain. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 11, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,106.80 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 24, 2025. The order is for ENVARSUS XR 1 mg tablets in a 30-count supply. This is a firm fixed-price, non-set-aside contract with performance at the company's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 3, 2025, valued at $1,288.86 for the supply of Envarsus XR 1 mg tablets (100-count) under a firm fixed price contract. The award was made through the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, indicating competitive award status. This delivery order is a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, valued at $5,135.85 for the supply of Envarsus XR 4 mg tablets (100 count) to support federal medical procurement needs. This firm fixed price delivery order, which must be completed by July 11, 2025, was awarded through open competition with no set-aside designation. The award is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,804.13 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets (100 count) on November 20, 2025. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by December 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,148.10 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Envarsus XR 1 mg tablets (100-count). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with federal medical procurement. The work will be performed at the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,811.00 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on November 3, 2025, with completion targeted for November 25, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 4 mg tablets (100-count) valued at $10,271.70 under firm fixed price terms. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 7, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,436.96 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on June 11, 2025, with a completion date of July 3, 2025. This firm fixed price, non-set-aside contract is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order falls under...